ミネソタ州における肥満症の臨床試験
ミネソタ州内の拠点で、肥満症に関する29件の研究が参加者を募集しています。
ミネソタ州内の都市
公式研究テキスト（英語）
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07533175A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
- International Diabetes Center, Minneapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07564414A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- University of Minnesota, Minneapolis
- Synexus Clinical Research US-MN, Richfield
被験者募集中第3相
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- Headlands Research - Twin Cities, Maplewood
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07823608A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- University of Minnesota Masonic Children's Hospital, Minneapolis
- Mayo Clinic - PIN, Rochester
- Children's Minnesota Pediatric Endocrinology Clinic & McNeeley Diabetes Center, Saint Paul
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Headlands Research-Twin Cities, Maplewood
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- Minneapolis Heart Institute Foundation, Minneapolis
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Mankato
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Mankato Clinic, Mankato
- Fairview Health Services M Health Fairview St Johns Hospital, Maplewood
- University of Minnesota, Minneapolis
被験者募集中第3相
18歳〜99歳 · 全性別 · 2026/09/16更新 · NCT07037459A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- International Diabetes Center At Park Nicollet, Minneapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Effect of ACCG-2671
- Research Site, Dilworth
被験者募集中第1/2相健康なボランティア歓迎
25歳〜75歳 · 全性別 · 2026/09/14更新 · NCT07815678Exercise Response in Humans With Obesity
- Mayo Clinic in Rochester, Rochester
被験者募集中観察研究
20歳〜45歳 · 全性別 · 2026/09/11更新 · NCT05857150A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Mankato
- ACCOMPLISH-2 Research Site, Minneapolis
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374tDCS With Cognitive Training to Reduce Impulsivity and Weight in Veterans With Obesity
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis
被験者募集中
18歳〜80歳 · 全性別 · 2026/09/08更新 · NCT05225233Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
- Children's Hospitals and Clinics of Minnesota, Minneapolis
被験者募集中第2相
7歳〜25歳 · 全性別 · 2026/08/19更新 · NCT05082519Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Mankato
- ACCOMPLISH-1 Research Site, Richfield
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361Upper Body Subcutaneous Exosome Release in Response to a Meal in Obesity
- Mayo Clinic in Rochester, Rochester
被験者募集中健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/08/05更新 · NCT07031297Fibrosis Lessens After Metabolic Surgery
- Mayo Clinic, Rochester
被験者募集中第4相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/07/31更新 · NCT06374875A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With Obesity
- Clinical Research Institute of Minnesota, Minneapolis
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/07/27更新 · NCT07728383Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention
- Minneapolis VA Health Care System, Minneapolis
被験者募集中
18歳以上 · 全性別 · 2026/07/22更新 · NCT06390345Phenotype-Tailored Lifestyle Intervention for Obesity: A Randomized Trial
- Mayo Clinic, Rochester
被験者募集中
18歳〜65歳 · 全性別 · 2026/06/11更新 · NCT06770049Regional Lipolysis and Adipocyte Lipolysis Protein Stimulation
- Mayo Clinic in Rochester, Rochester
被験者募集中早期第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/05/22更新 · NCT06416969Circadian Rhythms in Human Adipose
- Mayo Clinic, Rochester
被験者募集中健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/04/14更新 · NCT06891534Regional Lipolysis Insulin Regulation
- Mayo Clinic in Rochester, Rochester
被験者募集中早期第1相健康なボランティア歓迎
18歳〜65歳 · 全性別 · 2026/04/13更新 · NCT06392854Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- Mayo Clinic, Rochester
被験者募集中第4相参加者への支払いあり
18歳〜65歳 · 全性別 · 2026/03/11更新 · NCT07213466Insulin Regulation of Lipolysis and Lipolysis Proteins
- Mayo Clinic in Rochester, Rochester
被験者募集中早期第1相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2026/01/28更新 · NCT03866408Project SHINE (Sleep Health INitiative for Equity): Culturally Informing a Sleep Extension Intervention for African American Adults
- University of Minnesota, Minneapolis
被験者募集中第1/2相
21歳〜75歳 · 全性別 · 2025/12/17更新 · NCT06226077Weight Loss Through Mayo Clinic Diet
- Mayo Clinic in Rochester, Rochester
被験者募集中健康なボランティア歓迎
18歳〜64歳 · 全性別 · 2025/10/07更新 · NCT06862375Tirzepatide in PWS, HO and GNSO
- Children's Minnesota, Saint Paul
被験者募集中第4相
18歳〜26歳 · 全性別 · 2025/09/16更新 · NCT06901245ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。